Works matching DE "SODIUM-glucose cotransporters"

Results: 1912
    1

    The impact of sodium-glucose cotransporter-2 inhibitors on breast cancer and cancer-related mortality: a systematic review and meta-analysis of randomized controlled trials.

    Published in:
    BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-14304-8
    By:
    • Karimi, Mohammad Amin;
    • Khadem, Razieh;
    • Haraj, Alireza;
    • Farahani, Mehdi Azizabadi;
    • Charehsaz Avari Firouzeh, Pardis;
    • Azizinezhad, Arash;
    • Raki, Hasti Kianpour;
    • Belbasi, Mohaddeseh;
    • Bafrani, Melika Arab;
    • Deravi, Niloofar;
    • Khakpour, Yaser;
    • Habibi, Ali Faghih;
    • Aghsaghloo, Vahid
    Publication type:
    Article
    2

    Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity.

    Published in:
    Antioxidants, 2025, v. 14, n. 5, p. 612, doi. 10.3390/antiox14050612
    By:
    • Quagliariello, Vincenzo;
    • Di Mauro, Annabella;
    • Ferrara, Gerardo;
    • Bruzzese, Francesca;
    • Palma, Giuseppe;
    • Luciano, Antonio;
    • Canale, Maria Laura;
    • Bisceglia, Irma;
    • Iovine, Martina;
    • Cadeddu Dessalvi, Christian;
    • Maurea, Carlo;
    • Barbato, Matteo;
    • Inno, Alessandro;
    • Berretta, Massimiliano;
    • Paccone, Andrea;
    • Mauriello, Alfredo;
    • Fonderico, Celeste;
    • Maratea, Anna Chiara;
    • Maurea, Nicola
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Comparing the clinical outcomes across different sodium/glucose cotransporter 2 (SGLT2) inhibitors in heart failure patients: a systematic review and network meta-analysis of randomized controlled trials.

    Published in:
    European Journal of Clinical Pharmacology, 2021, v. 77, n. 10, p. 1453, doi. 10.1007/s00228-021-03147-4
    By:
    • Teo, Yao Hao;
    • Yoong, Celine Shuen Yin;
    • Syn, Nicholas L.;
    • Teo, Yao Neng;
    • Cheong, Jia Yang Alex;
    • Lim, Yoke-Ching;
    • Lee, Chi-Hang;
    • Yeo, Tiong-Cheng;
    • Chai, Ping;
    • Wong, Raymond C. C.;
    • Lin, Weiqin;
    • Sia, Ching-Hui
    Publication type:
    Article
    9

    SGLT2 inhibitors and euglycemic diabetic ketoacidosis.

    Published in:
    2021
    By:
    • Yousaf, Zohaib;
    • Ata, Fateen;
    • Khan, Adeel Ahmad;
    • Razok, Almurtada;
    • Akram, Jaweria;
    • Ali, Elrazi Awadelkarim Hamid;
    • Abdalhadi, Ahmed;
    • Danjuma, Mohammed I.;
    • Al Mohanadi, Dabia Hamad S. H.
    Publication type:
    Letter
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    SGLT2 inhibitors.

    Published in:
    SA Pharmaceutical Journal Incorporating Pharmacy Management, 2018, v. 85, n. 1, p. 72
    By:
    • Steyn, Lynda
    Publication type:
    Article
    24
    25
    26
    27
    28

    Evaluation of important human CYP450 isoforms and P‐glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail.

    Published in:
    Basic & Clinical Pharmacology & Toxicology, 2023, v. 132, n. 6, p. 487, doi. 10.1111/bcpt.13840
    By:
    • Neyshaburinezhad, Navid;
    • Shirzad, Nooshin;
    • Rouini, Mohammadreza;
    • Namazi, Soha;
    • Khoshayand, Mohammadreza;
    • Esteghamati, Alireza;
    • Nakhjavani, Manouchehr;
    • Ghasim, Hengameh;
    • Gloor, Yvonne;
    • Daali, Youssef;
    • Ardakani, Yalda H.
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50